Dimopoulos M, Tedeschi A, Trotman J, et al. Multinational, randomized phase 3 trial of ibrutinib-rituximab vs placebo-rituximab with Waldenström’s macroglobulinemia. EHA 2018, abstract S852.
Cardiovasculair risico na chemo- en radiotherapie bij vroeg stadium hodgkinlymfoom
sep 2021 | Lymfoom, Radiotherapie